Importance and Challenges of Studying Marketed Drugs: What Is a Phase IV Study? Common Clinical Research Designs, Registries, and Self-Reporting Systems-Reference-Cited by-同舟云学术

Importance and Challenges of Studying Marketed Drugs: What Is a Phase IV Study? Common Clinical Research Designs, Registries, and Self-Reporting Systems

Published:2007-09 Issue:9 Volume:47 Page:1074-1086
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Glasser Stephen P.,Salas Maribel,Delzell Elizabeth

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference63 articles.

1. Post-marketing surveillance: a UK/European perspective;Gough;Curr Med Res Opin.,2005

2. The one-person randomized controlled trial;Olsson;Qual Manag Health Care,2005

3. A risky business: the detection of adverse drug reactions in clinical trials and post-marketing exercises;Corrigan;Soc Sci Med.,2002

4. Is the randomized clinical trial the gold standard of research?;Simon;J Androl.,2001

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Development and Regulatory Considerations for Systemic Sclerosis Therapies;Scleroderma;2024

2. Efficacy and safety of anti-amyloid-β monoclonal antibodies in current Alzheimer's disease phase III clinical trials: A systematic review and interactive web app-based meta-analysis;Ageing Research Reviews;2023-09

3. Phase 4 clinical trials in the era of the Coronavirus Disease (COVID-19) pandemic and their importance to optimize the COVID-19 vaccination;Human Vaccines & Immunotherapeutics;2023-07-14

4. A Phase IV Trial of Proton Therapy in Children: The First Report from the SJPROTON1 Study;2022-11-30

5. Spontaneous adverse drug reaction reporting by community pharmacists: preparedness and barriers;Saudi Pharmaceutical Journal;2022-07